A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia.
Am J Cardiovasc Drugs
; 23(4): 441-454, 2023 Jul.
Article
in En
| MEDLINE
| ID: mdl-37395974
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dyslipidemias
/
Hypertension
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Am J Cardiovasc Drugs
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article